Sona Nanotech’s latest webinar replay is now available, CEO David Regan and CMO Dr. Carmen Giacomantonio discussed our innovative Targeted Hyperthermia Therapy (THT) for cancer treatment. They share promising preclinical results showing tumor elimination when THT is combined with standard immunotherapies. Learn how our patented biocompatible gold nanorods gently heat tumors from the inside out or more on our plans for the first-in-human study in 2025.